Phase 2 Clinical Trial for CMT1 and CMTX

Acceleron recruited adults with CMT1 and CMTX for a Phase 2 clinical trial studying investigational drug ACE-083.

Thank you for your interest in participating, but the study is fully subscribed and registration is closed.